ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 25 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $171,000 | – | 17,299 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden Green, Inc. | 69,782 | $774,000 | 0.67% |
| ARK Investment Management | 476,414 | $5,283,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 25,000 | $267,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $144,000 | 0.00% |
| Renaissance Technologies | 290,406 | $3,221,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 31,000 | $330,758,000 | 0.00% |
| MARSHALL WACE, LLP | 33,889 | $376,000 | 0.00% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 700 | $6,000 | 0.00% |
| SOA Wealth Advisors, LLC. | 327 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,135 | $35,000 | 0.00% |